IREN has deteriorated further since last week's note, with the stock now down 18% on the week and 43% over the past month — and the borrow market, which was already tightening sharply, has now reached its most constrained reading of the year.
The lending setup has gone from urgent to extreme. Availability collapsed to just 3.4% on July 17 — down from 10.8% a week earlier, a fall of nearly 69% in five sessions. That means roughly one share remains available for every 29 already borrowed, the tightest reading in the 52-week dataset. Short interest has continued to build, now at 29.1% of the free float, up another 17% on the week and 47% over the past month. More than 82 million shares are held short. What changed from last week's note is that availability, which had been swinging between 6% and 16%, has now stabilised at the floor — three of the last five sessions have printed below 7%. Cost to borrow remains oddly subdued at around 1.1%, up 35% on the week but still low in absolute terms for a name this heavily shorted. That combination — near-zero availability with cheap borrow — suggests the existing short base is well-established and the constraint is on new entrants rather than the current holders. Options traders are growing more defensive in parallel: the put/call ratio hit 1.08, its highest reading of the past year, running nearly 1.7 standard deviations above the 20-day average of 0.92. The ORTEX short score has edged up to 68.4, close to a six-month peak, reflecting the combination of high float-on-loan, tight availability, and softening momentum.
The Street remains broadly constructive, but the gap between analyst targets and market price has grown almost surreal. Eleven analysts rate IREN a buy, with Macquarie maintaining an Outperform and a $90 target as recently as July 15. Cantor Fitzgerald's target is $99 and B. Riley sits at $96. Even the most recent upgrade — Freedom Broker moving to Buy on July 6 with a $58 target — represents 72% upside from current levels. The analyst recommendation differential factor scores in the 100th percentile, meaning no peer ranks higher on the disparity between analyst optimism and current price. The bull case centres on IREN's Microsoft partnership, expanding AI compute capacity, and a new Australian campus — durable infrastructure plays with a long growth runway. Bears focus on the crypto mining revenue base, which remains volatile and cyclically exposed, alongside negative earnings and deeply negative free cash flow. The EV/EBITDA multiple has compressed to 3.4x, down nearly 9 points over the past month, reflecting how much of the prior valuation premium has been stripped out.
The peer group offers some context on scope. CIFR dropped 21% on the week, broadly in line with IREN. WULF fell 17% and MARA dropped 15%. CLSK, however, managed a 1.4% gain — a notable divergence suggesting the selloff is not perfectly uniform across the digital-asset infrastructure space. The co-CEOs, Daniel and William Roberts, remain the largest institutional holders, each at 6.6% of shares following a large increase reported as of July 1. BlackRock added materially in the June quarter, reporting 3.8 million new shares — but that data is now dated relative to the scale of the price move.
Next earnings are scheduled for August 28. The prior two prints produced a muted one-day reaction — a 4% decline in May after Q1 and roughly flat after the May 7 release — though the five-day drift was more pronounced in both cases. With availability at a 52-week low and short interest at a 52-week high heading into that date, the August print will determine whether the gap between analyst conviction and market positioning begins to close — or widens further.
See the live data behind this article on ORTEX.
Open IREN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
